Finance

Lists
Q2 2026 earnings • released • EPS miss -853.44% • Revenue miss -99.11%
See results
PBLS:NASDAQ
Parabilis Medicines Inc
$36.21
-3.21%
(-1.20) 1D
Aug 13, 10:59:28 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PBLS...
Open
$37.67
High
$37.67
Low
$36.04
Mkt. cap
4.22B
Avg. vol.
416.10K
Volume
25.30K
52-wk high
$37.83
52-wk low
$24.51
EPS
-$1.77
No. of employees
145
Open
$37.67
High
$37.67
Low
$36.04
Mkt. cap
4.22B
Avg. vol.
416.10K
Volume
25.30K
52-wk high
$37.83
52-wk low
$24.51
EPS
-$1.77
No. of employees
145
News stories
From web sources and news partners
About Parabilis Medicines Inc
CEO-
Employees145
Founded2015
Headquarters-
SectorBiotechnology
Websiteparabilismed.com
Analyst ratings
Based on 5 analysts giving stock ratings to PBLS in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for PBLS in the last 3 months.
Highest
Current $36.21
$45.00 (+24.28%)
Average
$41.75 (+15.30%)
Lowest
$40.00 (+10.47%)
Analyst
Recommendation
Action
Price target
Projected
Date
Charles Zhu
LifeSci Capital
Buy
Initiated
$42.00
+16%
07/18/2026
Gaurav Maini
LifeSci Capital
Buy
Initiated
$42.00
+16%
07/18/2026
Andrew Berens
Leerink Partners
Buy
Initiated
$40.00
+10.5%
07/06/2026
Umer Raffat
Evercore ISI
Buy
Initiated
-
-
07/06/2026
Tazeen Ahmad
Bank of America Securities
Buy
Initiated
$45.00
+24.3%
07/06/2026
Michael Schmidt
Guggenheim
Buy
Initiated
$40.00
+10.5%
07/05/2026
Last report
Just released
Today, 7:00 AM
Fiscal period
Q2 2026
EPS / Est. (USD)
-$2.32 / -$0.24
-853.44%miss
Revenue / Est. (USD)
148.00K / 16.67M
-99.11%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Mar 2026
Revenue
-
-
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
33.90M
37.75M
Total research and development expenses
-
-
Selling, general, and admin expenses
5.28M
9.70M
Operating expense
39.18M
47.45M
Total operating expenses
39.18M
47.45M
Operating income
-39.18M
-47.45M
Other non operating income
-
-
EBT including unusual items
-38.33M
-45.32M
EBT excluding unusual items
-38.33M
-45.32M
Income tax expense
-
-
Effective tax rate
-
-
Other operating expenses
-
-
Net income
-38.33M
-45.32M
Net profit margin
-
-
Earnings per share
-
-
Interest and investment income
1.26M
2.43M
Interest expense
-399.00K
-292.00K
Net interest expenses
858.00K
2.14M
Depreciation and amortization charges
-
-
EBITDA
-38.53M
-46.85M
Gain or loss from assets sale
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps